MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 721 to 740 of 5,858 approvalsPage 37 of 293

RINVOQ EXTENDED-RELEASE TABLET 30MG

Approval Number: SIN16518P
Approval: Jun 21, 2022

AVOFER INJECTION 100MG/5ML

Approval Number: SIN16513P
Approval: Jun 16, 2022

VABYSMO SOLUTION FOR INJECTION 6MG/0.05ML

Approval Number: SIN16514P
Approval: Jun 16, 2022

FYCOMPA ORAL SUSPENSION 0.5MG/ML

Approval Number: SIN16512P
Approval: Jun 10, 2022

FOSACORD 70 TABLET 70 MG

Approval Number: SIN16511P
Approval: Jun 10, 2022

SOLICIN-5 FILM COATED TABLET 5 MG

Approval Number: SIN16510P
Approval: Jun 9, 2022

TELSAT TABLET 80 MG

Approval Number: SIN16505P
Approval: Jun 1, 2022

TELSAT TABLET 40 MG

Approval Number: SIN16506P
Approval: Jun 1, 2022

TIVICAY DISPERSIBLE TABLET 5 MG

Approval Number: SIN16504P
Approval: May 30, 2022

REGIVELL SPINAL HEAVY INJECTION 0.5% W/V

Approval Number: SIN16501P
Approval: May 24, 2022

ETORICOXIB AUXILTO FILM-COATED TABLETS 120MG

Approval Number: SIN16499P
Approval: May 20, 2022

ETORICOXIB AUXILTO FILM-COATED TABLETS 90MG

Approval Number: SIN16500P
Approval: May 20, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.